腋窝手术范围与区域淋巴结照射对亚临床乳腺癌相关淋巴水肿风险的影响:一项随机对照试验
本研究比较生物阻抗光谱(BIS)与卷尺测量(TM)按腋窝手术范围和区域淋巴结照射(RNI)检测亚临床乳腺癌相关淋巴水肿(sBCRL)的风险。484例患者随机接受TM或BIS监测,中位随访20.5个月,BIS触发率13.5%低于TM的25.6%(P<.001),且BIS更能区分RNI类型和腋窝手术对sBCRL风险的影响;结论支持BIS用于治疗后监测以早期干预。
要点
- BIS触发sBCRL率13.5%显著低于TM的25.6%(P<.001)。
- 广泛RNI在SNB后显著增加BIS触发sBCRL(33.3% vs 12.9%,P=.03)。
- ALND或广泛RNI患者需密切监测BCRL。
核心结论
- BIS触发率较低且更能区分RNI类型和腋窝手术对sBCRL风险的影响,支持其用于治疗后监测以检测sBCRL并启动早期干预。
- sBCRL风险随腋窝治疗范围扩大而增加,ALND或广泛RNI患者需密切监测BCRL。
- 需更长随访以确定进展为临床淋巴水肿的比率。
研究设计与样本
- 随机对照试验,患者随机接受TM或BIS监测。
- 共检查484例患者(498例中109例触发sBCRL),中位随访20.5个月。
- BIS≥6.5 L-Dex单位或TM体积变化≥5%且<10%高于术前基线触发sBCRL。
- 放疗分类为局限RNI(仅腋窝I/II级)或广泛RNI(腋窝III级或锁骨上区伴或不伴I/II级)。
主要发现
- 109/498例(21.9%)触发sBCRL,BIS 13.5% vs TM 25.6%(P<.001)。
- 未接受RNI患者中,BIS触发SNB 12.9% vs ALND 25.0%(P=.18)。
- SNB后广泛RNI显著增加BIS触发(33.3% vs 12.9%;P=.03),ALND后无显著差异(30.8% vs 25.0%;P=.69)。
- TM在多数亚组触发率>25%,在区分RNI或腋窝手术的sBCRL风险方面劣于BIS。
关键数值与推荐
- BIS触发sBCRL阈值:≥6.5 L-Dex单位。
- TM触发sBCRL阈值:体积变化≥5%且<10%高于术前基线。
- BIS触发率13.5% vs TM 25.6%(P<.001)。
- SNB后广泛RNI vs 无RNI的BIS触发率33.3% vs 12.9%(P=.03)。
临床怎么用
- 支持使用BIS进行治疗后监测以检测sBCRL并启动早期干预。
- ALND或广泛RNI患者需密切监测BCRL。
- TM在区分RNI或腋窝手术的sBCRL风险方面劣于BIS。
局限性
- 需更长随访以确定进展为临床淋巴水肿的比率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the risk of subclinical breast cancer-related lymphedema (sBCRL) using bioimpedance spectroscopy (BIS) or tape measure (TM) by the extent of axillary surgery and regional nodal irradiation (RNI). METHODS AND MATERIALS: Patients were randomized to surveillance with TM or BIS. A BIS ≥6.5 L-Dex units or TM volume change ≥5 and <10% above presurgical baselines "triggered" sBCRL. The incidence of sBCRL by sentinel node biopsy or axillary lymph node dissection (ALND) with or without RNI was examined for 484 patients. Radiation was categorized as "limited RNI" (axilla level I/II only) or "extensive RNI" (axilla level III or supraclavicular fossa with or without level I/II). RESULTS: At a median follow-up of 20.5 months, 109 of 498 patients (21.9%) triggered sBCRL (BIS 13.5% vs TM 25.6%; P <.001). In patients not receiving RNI, BIS triggered 12.9% of patients undergoing SNB and 25.0% undergoing ALND (P = .18). Extensive RNI significantly increased triggering with BIS versus no RNI after sentinel node biopsy (SNB; 33.3% vs 12.9%; P = .03) but not ALND (30.8% vs 25.0%; P = .69). Triggering by TM was greater than 25% for most subgroups and was inferior to BIS in discriminating the risk of sBCRL by utilization of RNI or axillary surgery. CONCLUSIONS: The lower triggering rates with BIS and its better discrimination of the risk of sBCRL by receipt and type of RNI compared with TM support its use for posttreatment surveillance to detect sBCRL and to initiate early intervention. The risk of sBCRL increased with more extensive axillary treatment. Patients having ALND or extensive RNI require close surveillance for BCRL. Longer follow-up is required to determine rates of progression to clinical lymphedema.
引用
- Boyages J, Vicini FA, Shah C, et al. The Risk of Subclinical Breast Cancer-Related Lymphedema by the Extent of Axillary Surgery and Regional Node Irradiation: A Randomized Controlled Trial. Int J Radiat Oncol Biol Phys. 2020. PMID: 33127493. doi:10.1016/j.ijrobp.2020.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。